Precision Haematological Cancer Medicine

This text additionally provides an authoritative state of the art review of the preclinical and clinical aspects of haematological malignancies and how they might impact precision oncology becoming the standard of care. It is concise, easily readable, and yet provides an authoritative review of the â€~state of the art’.

Precision Medicine and Future Therapeutics. Classifications and Risk Factors. Historical Milestones. Acute Myeloid Leukaemia. Acute Lymphoblastic Leukaemia. Chronic Myeloid Leukaemia. Myeloproliferative and Related Neoplasms. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms. Leukaemias of Mature B- and T/NK-Cells. Hodgkin Lymphoma. Non-Hodgkin Lymphoma. Plasma Cell Neoplasms. Principal Treatment-Related Side Effects. Concluding Thoughts.